pharma news today obesity glp-1 RAs gain popularity as cure for obesity, get explored for NASH, CVDs Weight loss with GLP-1 medicines

Request thyroid, metabolic, and nutritional lab work

However, Novo Nordisk pointed out that the study primarily focused on diabetes patients taking a low dose of semaglutide, rather than typical weight-loss use, for which the company's higher-dose Wegovy pill is approved

Theres also limited data on the use of GLP-1s during pregnancy, and Dr

Long-term timing considerations As you settle into a GLP-1 protocol over months, your side effect profile typically improves significantly

Dods and Donnelly, 2015), which correlates with available data for GCGR (Siu et al., 2013)

Conclusion Understanding glp-1 vs wegovy helps patients make informed decisions